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Abstract
Background: Many of the adverse outcomes experienced by mothers and babies are directly related to the health
of the woman prior to pregnancy. This preconception period is a unique window of opportunity when women are
often more motivated to optimise health and change their lifestyle in preparation for pregnancy. Several risk factors
in the preconception period can contribute to adverse perinatal outcomes. These risk factors can be divided into
three broad areas: biomedical, social and environmental. Mobile phone applications as a behaviour change
intervention have the potential to address these risks through supporting the provision of information, healthier
lifestyles and informed decision-making. The aim of this systematic review is to assess the effectiveness of mobile
phone applications in promoting behaviour change and improving long-term outcomes for mother and babies, in
women of reproductive age.
Methods: This review will include trials that assess any mobile phone application (app) that assist women of
reproductive age to optimise health behaviours. Randomised controlled trials, quasi-randomised controlled trials
and cluster-randomised trials will be included. The search strategy will use both MeSH and keyword combinations
to search databases including the WHO Global Health Library, CINHAL, The Cochrane Library, Embase and MEDLINE
for relevant studies. Retrieved citations will be screened independently by two authors to assess eligibility. Studies
will be selected only if the intervention was commenced prior to pregnancy. Comparisons will be made including
mobile phone applications versus text messaging-based communications or paper-based, face-to-face or telephone
conversations and standard care or no specific intervention. The Cochrane Handbook for Systematic Reviews of
Interventions will be utilised to assess the quality of included randomised studies. Primary and secondary outcomes
will be compared and analysed. Results of the review will be reported using the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines.
Discussion: This systematic review is the first to assess the effects of preconception mobile phone app behaviour
change and educational interventions in improving future pregnancy and maternal and child outcomes, in women
of reproductive age.
Systematic review registration: PROSPERO 2017:CRD42017065903.
Keywords: Apps, Mobile, Preconception, Prenatal care, Perinatal, Reproductive health, Reproductive age, Maternal,
Infant, Behaviour change
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: lmus9038@uni.sydney.edu.au
1Sydney Medical School, Charles Perkins Centre, The University of Sydney,
The Hub, Level 2, John Hopkins Drive, Camperdown, NSW 2006, Australia
2Sydney Local Health District, Sydney, NSW, Australia
Full list of author information is available at the end of the article
Musgrave et al. Systematic Reviews            (2019) 8:86 
s://doi.org/10.1186/s13643-019-0996-6
Background
Positive or adverse outcomes for mothers and babies are
often directly related to the health of the woman prior
to pregnancy. The preconception period is a unique win-
dow of opportunity when women are often more moti-
vated to optimise health and change their lifestyle in
preparation for pregnancy. Positive changes have the po-
tential to impact on the woman’s health as well as the
health of the next generation [1, 2]. The focus of the sys-
tematic review is women of reproductive age, whether
they plan to get pregnant or not. Generally all women
can benefit from key preconception health lifestyle and
behaviour changes such as getting more physically ac-
tive, healthy eating, losing weight, quitting smoking, and
alcohol and substance use reduction. Lifestyle and be-
haviour changes that reduce the risk of illness and dis-
ease are also beneficial for planning for pregnancy [3].
The Centers for Disease Control and Prevention
(CDC) defines preconception care as any intervention
that aims to detect and change biomedical, behavioural
and social risks to a woman’s health or pregnancy out-
come through preventive primary health care and man-
agement [4]. Several preconception risk factors may
contribute to adverse perinatal outcomes. These can be
divided into three broad groups: biomedical, social and
environmental.
Biomedical risks include weight (under and over-
weight/obese); malnutrition, chronic medical condi-
tions such as diabetes and hypertension, infectious
diseases such as sexually transmitted infections, gen-
etic disorders, consanguinity, mental health disorders
and advanced maternal age [5]. For example, obesity
has been associated with reproductive disorders and
is linked to maternal and neonatal adverse outcomes
[6]. Evidence suggests that the antenatal period may
be too late to address the risk associated with mater-
nal obesity and that ideally pre-pregnancy interven-
tions should be utilised in order to improve outcomes
for the mother and baby [6, 7].
Having a healthy lifestyle preconception is likely to
lead to better reproductive outcomes and theoretically
could decrease societal expenditure. For example, a sys-
tematic review by Wahabi et al. highlighted that there is
a high return on investment when preconception care in
women with pre-gestational diabetes is offered. Findings
showed a reduction of preterm birth, congenital malfor-
mations and perinatal mortality [8, 9].
Social risks include unwanted pregnancies; unsafe
abortions; minimal inter-pregnancy intervals; coerced
sex and intimate partner violence; substance abuse of to-
bacco, alcohol and illicit drugs; and excessive caffeine.
Environmental exposures include heavy metals and che-
micals, ionising radiation and heat, heavy lifting and pro-
longed standing [5, 10].
There are currently more than 165,000 medical and
health applications available to healthcare consumers
with over 90% free and publicly available through Apple
iOS and Google app platforms in Australia [11]. Smart-
phone ownership and app use in Australia is high with
between 81% and 88% of citizens possessing a smart-
phone [12, 13]. The majority of owners are aged between
18 and 24 and spend most of their time on the phone
using apps [14]. Lupton and Pedersen’s online Australian
survey of women aged between 18 and 45 found that the
use of pregnancy and parenting apps was common [15].
These findings support that women of reproductive age
are increasingly turning to web-based and mobile health
platforms to receive health information rather than rely-
ing on face-to-face and paper-based delivery methods
[16]. This trend towards the use of mobile health opens
up an opportunity to reach those women who are less
likely to engage with health care providers or are yet
to do so. Several behaviour change interventions have
been identified as having the potential to mitigate
risks and support healthier lifestyles and informed
decision-making. Risk-reduction interventions include
weight loss programs that incorporate diet and exer-
cise, dietary supplementation, optimising glycaemic
control, immunisation, screening and treatment of
disease and disorders, genetic counselling and preg-
nancy planning [5]. Education interventions include ad-
vice on modern contraceptives, pregnancy spacing advice,
addressing domestic violence and community awareness
programs that support women to feel empowered [5]. It is
essential that women have easily accessible comprehensive
care and support that is founded in evidence-based prac-
tice and accessible across all socio-economic groups.
Mobile health or ‘mHealth’ is defined as those health
technologies within the area of electronic health or
‘eHealth’ that provide health services and information via
mobile technologies such as mobile phones and Personal
Digital Assistants (PDAs) [17]. Mobile applications that
assist consumers, in this case women of reproductive age,
in wellness and disease prevention, are often referred to as
mHealth applications or ‘apps’ [11]. Mobile health apps
have several functions including the transmission of infor-
mation, supporting decisions making, information ex-
change, and emotional support, reinforcing self-care and
managing requirements for health care services [18].
There is evidence of benefit for mHealth interventions
in adults that offer support and education with the
intention to change high-risk behaviours such as smok-
ing, poor dietary and exercise habits; however, there is a
lack of evidence to support their use before or during
pregnancy [18, 19]. Previous meta-analyses of these in-
terventions have shown efficacy of applications targeting
physical activity and weight loss; however, these studies
are not generalizable to women of reproductive age and
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lack an examination of long-term effects or follow-up
[20].
Women from high-income countries are considerable
users of mobile phone applications to access social media
and lifestyle advice. Often, women will turn to digital
media for pregnancy information and advice. This was
confirmed by Rodger et al. who reported that in South
Australia, 40% of women had used a pregnancy-related
smartphone app to access information about pregnancy
[21]. Wallwiener et al. found that Australian women who
utilised mobile health in pregnancy tended to be young,
having their first baby, less healthy and more influenced
by the information they receive [22]. This represents an
opportunity to improve both physical and mental health
outcomes and support in pregnancy and early parenthood
for those who may benefit most [23].
Despite the large number of health and medical apps
on the market, there is limited research into how they
impact on behaviour changes in women of reproductive
age prior to pregnancy. A small Western Australian
qualitative study by Hearn et al. reported that women
want apps that interface with reliable evidenced-based
websites so that they can access information on common
fears as well as tools for personalising weight, nutrition
and fitness management [24]. These findings are sup-
ported by a work done by Lupton and Pedersen which
suggests that women want mobile apps that present in-
formation that is contextualised and can be used as a
tool to support decision-making [15].
It is important to do this review and evaluate the ef-
fectiveness of mobile apps as multiple apps exist, and
they are widely used by women despite limited evidence
regarding improved health outcomes or potential risks.
Understanding the broader implications and the effective-
ness of apps, both before and during pregnancy, is essen-
tial for healthcare professionals to recommend these
technological interventions as tools that positively impact
on maternal and neonatal outcomes. A thorough under-
standing of how women of reproductive age interact and
are represented by apps as well as the validity and accur-
acy of the information provided is particularly relevant
and needs to be examined to inform further research.
The quality, efficacy, reliability and security of apps re-
quires further scrutiny in order for clinicians to be able
to give better guidance around their use so that health-
care providers can be better informed when designing,
developing and implementing effective interventions
using such technology [25]. With the cost of health care
increasing, health care systems are continually under
pressure to evaluate the cost-effectiveness and potential
cost savings for healthcare. With the potential of large
cost savings and widespread accessibility, mobile health
apps offer a potential adjunct to face-to-face pregnancy
planning care. However, the unregulated nature of this
technology and the lack of direct comprehensive informa-
tion delivered may lead to insufficient, inappropriate and
missed opportunities to provide extra information [26].
On the other hand, women across all socio-economic
groups could potentially reap the benefits of having access
to information 24 h a day which could optimise their
health and in the long term, reduce medical intervention
in pregnancy and birth [25].
The most recent scoping review by Hemsing et al. of
preconception health care interventions consolidates
knowledge and information related to current precon-
ception and inter-conception health care interventions
[1]. Daly et al. recently published a systematic review of
the effect of mobile app interventions on influencing
healthy maternal behaviour and improving perinatal health
outcomes. This paper stated that ‘no clear conclusions
could be drawn on the effects of mobile application inter-
ventions during pregnancy on maternal knowledge, behav-
iour change, and perinatal health outcomes’ [27, 28]. To
the best of our knowledge, the protocol for our intended
systematic review is the first to address preconception be-
haviour change through mobile phone apps. Once the re-
view is complete, it is hoped that findings will contribute to
the knowledge base available to health facilities and clini-
cians and aid in the decision-making for integration of
these technology platforms into standard care.
Aim
The aim is to assess the effectiveness of mobile phone
applications in women of reproductive age for promot-
ing healthier behaviour change and improving future
outcomes for mothers and babies. These behaviours may
include advice about healthy weight, diet, exercise, re-
duction or cessation of smoking and alcohol/drug taking
and psychosocial needs, e.g. anxiety and depression.
Methods
Protocol
The Preferred Reporting Items for Systematic Reviews
and Meta-Analysis Protocols (PRISMA-P) guidelines for
reporting systematic reviews evaluating health care inter-
ventions will be used [29]. A PRISMA-P checklist is at-
tached (Additional file 1).
Inclusion criteria
Trials assessing behaviour change interventions, self-
management of wellness and disease prevention man-
agement (single or combined) will be included. Rando-
mised controlled trials, quasi-randomised controlled
trials and cluster-randomised trials will be included.
Studies published as abstract only will be included only
if sufficient information is available or we are able to
contact the authors and gain the information required.
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Participants
The participants are non-pregnant women of reproduct-
ive age, whether they are planning a pregnancy or not.
Interventions
Randomised controlled trials, quasi-randomised con-
trolled trials and cluster-randomised trials that aim to
assess the effects of mobile application-based interven-
tions on knowledge or behaviour of women of repro-
ductive age will be considered for inclusion. Mobile
application-based interventions will be included if they
provide general information for women of reproductive
age or focus on a specific risk factor relevant to future
perinatal outcome. Interventions that support informa-
tion delivery, decision-making, self-care and behaviour
change or risk reduction strategies/advice will be in-
cluded. There will be no restrictions on who has devel-
oped or funded the intervention, therefore we will
include both commercially developed apps as well as
apps developed by hospitals, health systems or other or-
ganisations. Interventions that are individualised with
capabilities such as self-monitoring, intention formation,
specific goal setting and review and feedback of goals
will be included.
Examples of these include:
 Targeted pregnancy planning support and advice
about healthy weight, diet, exercise, reduction or
cessation of smoking and alcohol/drug taking
 Decision-making support to address specific physical
and psychosocial needs such as perinatal mental
health, e.g. anxiety and depression
Studies will be excluded if they satisfy any of the fol-
lowing criteria:
 Do not use a mobile application
 The mobile phone is used solely for telephone
conversations or text messaging
 Do not describe mobile application interventions for
women of reproductive age (as opposed to health
care professionals, women’s partners)
 The physical effects of the mobile phone usage are
the focus of the study, e.g. adverse outcomes of
radiation
Comparators
The review will assess the following comparisons:
1. Mobile phone applications versus text messaging-
based communications or paper-based
2. Mobile phone applications versus face-to-face or
telephone conversations
3. Mobile phone applications versus standard care or
no specific intervention
Outcome measures
Primary outcomes
 Change in behaviour(s) as defined by trial author
relative to the goal of the intervention for example:
○ Healthier lifestyle choices;
○ Reduced risky behaviours, e.g. smoking cessation,
alcohol intake cessation or reduction;
○ Increase in physical activity;
○Weight control or reduction in adiposity;
○ Diabetes management, i.e. blood glucose control;
○ Improved nutrition;
○ Optimum management of disease symptoms, e.g.
reduction of blood pressure in hypertensive disease
or management of thyroid disease; and
○ Reducing unwanted pregnancies.
Secondary outcomes
 Self-efficacy (as defined by trial authors using a
validated scale such as the Rosenberg self-esteem
scale) [30]
 Psychosocial outcomes such as depression and
anxiety (as defined by trial authors and measured
using a validated tool, e.g. Cambridge Worry Scale
[31], State-Trait Anxiety Index [32] or Edinburgh
Depression Scale [33]
 General health (as defined by trial authors using
standardised measure such as a general health
assessment tool)
 Knowledge of targeted intervention topic, e.g. the
biomedical, social or environmental risk (as defined
by trial author)
 Evaluation of the intervention (as reported by the
trial authors, e.g. adherence lifestyle
recommendations)
 Health service utilisation (as reported by trial
authors, e.g. outpatient clinic appointment for
management of health or lifestyle, interaction with
health service program, interaction with GP
services, use of inpatient services or length of stay in
hospital)
Outcomes specific to unintended pregnancy
 Pregnancy intention (mistimed, ambivalent or as
reported by trial authors, e.g. a psychometrically
valid measure of pregnancy intention that assesses
intention on a continuous scale, such as the London
Measure of Unplanned Pregnancy [34, 35].
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 Health service utilisation (as reported to trial
authors e.g. family planning clinic, contraceptive
counselling, pregnancy test referral, abortion options
or services).
 Miscarriage.
Outcomes specific to pregnancy
Maternal
 Maternal morbidity (major)—combination of near-
miss mortality, unexpected admission to the inten-
sive care unit or death, as defined by the World
Health Organization (WHO)
 Antepartum haemorrhage
 Postpartum haemorrhage
 Gestational diabetes
 Pre-eclampsia
 Mode of birth
 Induction of labour
 Pain relief in labour
 Successful initiation of breastfeeding
 Maternal satisfaction
 Antenatal or postnatal depression
 Unanticipated admission to the hospital postnatally
Neonatal
 Perinatal morbidity (major—unexpected admission
to intensive care unit)
 Stillbirth
 Neonatal death
 Mode of birth
 Gestational age at birth
 Small for gestational age (SGA)—birthweight less
than the 10th percentile (using growth chart defined
by trialist)
 Large for gestational age (LGA)—birthweight greater
than the 90th percentile (using growth chart defined
by trialist)
 Infant feeding method at 3 months
 Unanticipated admission to the hospital
Setting
There will be no restrictions by type of setting. We ac-
knowledge that the study setting is very important and
may impact on how a woman experiences her repro-
ductive years, pregnancy and consequently the impact
on maternal and neonatal outcomes. We endeavour to
comment on the setting as defined by trialist, for ex-
ample socioeconomic group, age, marital status, family
structure, employment status and refugee status.
Time frame
Selected studies will provide women of reproductive age
about behaviour change interventions or education to
reduce or negate biomedical, social or environmental
risks preconception.
Search methods for identification of studies
The following methods section of this protocol is based
on the standard template used by the Cochrane Preg-
nancy and Childbirth Group.
Electronic searches
We will search for trials using the following methods:
1. Monthly searches of the Cochrane Central Registry
of Controlled Trials (CENTRAL);
2. Weekly searches of MEDLINE (Ovid);
3. Weekly searches of Embase (Ovid);
4. Monthly searches of CINAHL (EBSCO); and
5. Hand searches of journals and the proceedings of
major conferences.
Search results are screened by two people, and the full
text of all relevant trial reports identified through the
searching activities described above is reviewed.
In addition, we will search ClinicalTrials.gov and the
WHO International Clinical Trials Registry Platform
(ICTRP) for unpublished, planned and ongoing trial re-
ports using the search terms in Additional file 2.
Searching other resources
We will search the reference lists of retrieved studies for
further eligible studies. We will not apply any date or
language restrictions.
Search strategy
The search strategy was developed by the primary au-
thor with input from all authors. Subject heading and
keywords will be searched electronically in all fields. The
search will be repeated prior to the final analysis, and
any retrieved studies will be incorporated.
Search terms will be adapted for use with bibliographic
databases in combination with database-specific filters
for controlled trials, where these are available. Syntax
and subject headings will be adapted dependant on the
particular database to be searched. An example of search
terms and strategy is provided in Additional file 2.
Study data management
Data collection and analysis
The following methods will be used for assessing studies
identified by the search.
Selection of studies
Retrieved studies will be reviewed independently by two
authors. Discrepancies will be resolved by a third author.
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We will create a study flow diagram using PRISMA-P
to map out the number of records identified, included
and excluded [29].
Data extraction and management
EndNote reference management software will be utilised
to categorise studies identified. Results from individual
databases will be organised in one EndNote library with
duplicates removed. We will design a form to extract
data. For eligible studies, two review authors will extract
the data using the agreed form. We will enter data into
the Review Management software (RevMan 5.3) and
check for accuracy [36].
Assessment of risk of bias in included studies
Assessment of quality
The Cochrane Handbook for Systematic Reviews for in-
terventions will be used to assess the risk of bias for the
randomised controlled trials. Categorical judgements will
be made using the following domains in the guideline
selection bias: performance bias, detection bias, attrition
bias, reporting and all other bias. The likely impact and
bearing of any bias will be assessed through sensitivity
analysis [37].
Assessment of the evidence—GRADE
The Grades of Recommendation, Assessment, Develop-
ment and Evaluation (GRADE) approach will be utilised
to evaluate the quality of the body of evidence. Study
limitations, consistency of effect, imprecision, indirect-
ness and publication bias will be considered for specific
outcomes and the evidence graded accordingly [38].
Summary of findings
Findings of the effect and quality of the interventions
will be summarised in a table using the GRADE ap-
proach [39]. Data will be imported from RevMan [36]
using GRADE Profiler [40] and the following outcomes
will be presented:
 Change in behaviour pre-conception
 Self-efficacy
 Knowledge of targeted intervention
 Maternal morbidity (major)
 Maternal mortality
 Neonatal morbidity (major)
 Perinatal mortality
Measures of treatment effect and unit of analysis
Analysis will be conducted for randomised controlled trials
(RCTs), and the results will be represented as risk ratios
(RR) with 95% confidence intervals (CI). Mean difference
will be used for trials reporting continuous data, and a stan-
dardised mean difference will be used to combine trials
measuring the same outcome but utilised different
methods. The individual will be used as the unit of analysis
but where cluster-randomised trials are assessed, a statisti-
cian will be consulted.
Management of missing data
In the case of missing data, we will describe the number
of participants with missing data in the ‘Results’ section
and the ‘Characteristics of included studies’ table. We
will only present results for the available participants.
We will contact the authors of all published studies if clar-
ifications are required or to provide additional informa-
tion. Missing data and information will be investigated in
view of the overall assessment of the effectiveness of the
intervention and trial the author claims. We will discuss
the implications of the missing data in the ‘Discussion’
section of the review.
Assessment of heterogeneity and bias reporting
Assessment of heterogeneity between studies will be
conducted with a comparison of study settings, design
and population. We plan to assess the degree of hetero-
geneity using I2 statistics and examine the total variation
across all studies. If substantial heterogeneity is found,
this will be further explored using sensitivity analyses
and pre-specified subgroups. If sufficient numbers of
studies are found, data from the included studies will be
assessed using a funnel plot. This will give an indication
of the likelihood of publication bias.
Data synthesis
RevMan 5.3 [36] software will be used for statistical ana-
lysis. Relative risks RR with 95% CIs will be estimated
using fixed and random effects models as appropriate,
and the systematic review and meta-analysis will be re-
ported according to the Preferred Reporting Items for
Systematic Reviews (PRISMA) guidelines.
In trials reporting the same intervention with a similar
population, fixed-effect meta-analysis will be used as it will
be assumed that these studies are measuring the same
treatment effect. If the primary treatment effects vary be-
tween studies, random-effect analysis will be conducted to
produce a summary. Random-effects analysis results will be
presented as average treatment effect with 95% CIs and es-
timates of T2 and I1. Where the same intervention and
comparator are used with the same outcome measure, re-
sults will be aggregated using random-effects meta-analysis.
If this is not possible or inappropriate, a tabular and narra-
tive approach will be employed.
Subgroup analyses
If sufficient data is available, we plan to investigate using
subgroup analysis for the following subgroups:
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 Setting: low- or middle-income country versus high-
income country
 Parity: previous pregnancy vs no previous pregnancy
low or medium risk
 Women of reproductive age versus high-risk women
of reproductive age
 Socio-economic status: advantaged vs disadvantaged
Discussion
Women from high-income countries use mobile phone
applications widely to access social media and lifestyle
advice particularly when gathering information about
women’s reproductive health and pregnancy. This sys-
tematic review will be the first to assess the effects of
mobile app behaviour change and educational interven-
tions in all women of reproductive age, whether plan-
ning pregnancy or not. We are purposefully not just
targeting pregnancy planners as we speculate that those
who need behavioural change interventions are less
likely to plan pregnancy [41].
Findings may influence health policy makers and clini-
cians when considering the implementation of mobile
apps in the preconception period as an intervention to
manage and reduce the risk of known biomedical, social
and environmental consequences. Implementation of
this technology may reduce healthcare costs and im-
prove outcomes for mothers, babies and children.
Additional files
Additional file 1: PRISMA-P checklist. (DOCX 29 kb)
Additional file 2: Search strategy and terms. The strategy will be
adapted for individual databases searched. (DOCX 25 kb)
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